Log In
Print this Print this


Also known as: cAd3-EBO Z

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionRecombinant chimpanzee adenovirus type 3 (ChAd3) vector vaccine carrying the wild-type Ebola glycoprotein from the Zaire Ebola strain
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication DetailsPrevent Ebola virus infection
Regulatory Designation
PartnerNational Institutes of Health;
University of Maryland

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today